Maria Sorokina

8PUBLICATIONS
46CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Mar 14, 2026
Overcoming Chemoresistance in Glioblastoma: Mechanisms, Therapeutic Strategies, and Functional Precision Medicine.

Maria Y Kordyukova, Timofey K Bulgakov, Maria A Sorokina

|Mar 13, 2025
Inhibition of Thioredoxin-Reductase by Auranofin as a Pro-Oxidant Anticancer Strategy for Glioblastoma: In Vitro and In Vivo Studies.

Nelly Chmelyuk, Maria Kordyukova, Maria Sorokina

|Nov 15, 2024
Author Correction: Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|Jun 17, 2024
Duvelisib plus romidepsin in relapsed/refractory T cell lymphomas: a phase 1b/2a trial.

Steven M Horwitz, Ajit J Nirmal, Jahan Rahman

|Mar 30, 2024
Procrustes is a machine-learning approach that removes cross-platform batch effects from clinical RNA sequencing data.

Nikita Kotlov, Kirill Shaposhnikov, Cagdas Tazearslan

|Jul 12, 2023
Longitudinal Molecular Analysis of Tumor Exome and Transcriptome to Evaluate Clonal Evolution and Identify Novel Therapeutic Targets in Thymoma.

Christopher S Nabel, Yin P Hung, Anna Kurilovich

Pageof 2

Frequent Collaborators

4 joint publications

Olga M Kudryashova

3 joint publications

Nikita Kotlov

3 joint publications

Nara Shin

2 joint publications

Jahan Rahman